Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Immunology|August 28, 2003
Interleukin-12 and interleukin-2-induced invariant natural killer T-cell cytokine secretion and perforin expression independent of T-cell receptor activationRunhua Hou, Olga Goloubeva, Donna S Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Divergent effects of castration on prostate cancer in TRAMP mice: possible implications for therapyYao Tang, Linbo Wang, Olga Goloubeva, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 19, 2007
Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase modelGauri J Sabnis, Luciana Macedo, Olga Goloubeva, et al.
Cancer Research|June 19, 2008
Stopping treatment can reverse acquired resistance to letrozoleGauri J Sabnis, Luciana F Macedo, Olga Goloubeva, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2007
Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine modelTonya C Walser, Xinrong Ma, Namita Kundu, et al.
Breast Cancer Research and Treatment|September 17, 2008
Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK functionNamita Kundu, Xinrong Ma, Dawn Holt, et al.
Cancer Research|January 20, 2011
Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozoleGauri J Sabnis, Olga Goloubeva, Saranya Chumsri, et al.
The Journal of Headache and Pain|October 24, 2021
Differences in gray matter volume in episodic migraine patients with and without prior diagnosis or clinical care: a cross-sectional studyShana A B Burrowes, Olga Goloubeva, Michael L Keaser, et al.
Oncoimmunology|March 14, 2013
A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasisXinrong Ma, Dawn Holt, Namita Kundu, et al.
Molecular and Cellular Neurosciences|March 22, 2002
The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exitJustine J Cunningham, Edward M Levine, Frederique Zindy, et al.
Pageof 9